alantolactone has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad Khan, MK; Khan, M; Li, T; Ma, T; Nawaz, F; Rasul, A; Sun, M; Zheng, Y | 1 |
Lei, JC; Liu, YW; Yin, Y; Yu, JQ; Zou, GL | 1 |
2 other study(ies) available for alantolactone and Liver Neoplasms
Article | Year |
---|---|
Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction.
Topics: Acetylcysteine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Glutathione; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Signal Transduction; STAT3 Transcription Factor; Transcriptional Activation | 2013 |
Alantolactone induces activation of apoptosis in human hepatoma cells.
Topics: Apoptosis; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 8; Cytochromes c; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; Poly(ADP-ribose) Polymerases; Sesquiterpenes, Eudesmane | 2012 |